Two former investigators have filed suit against GlaxoSmithKline, charging the drug company with intentionally providing false information that resulted in actions that led to wrongful imprisonment.
According to The New York Times, the investigators were convicted of illegally obtaining the private records of Chinese citizens during a routine investigation of a whistleblower within GlaxoSmithKline. The investigation was intended to prove accusations of widespread corruption within the company were false. Instead, investigation found the claims to be true. The result of the initial whistleblowing claim was a $3 billion renminbi (approximately $500 million) fine for bribes paid to doctors. The fine was issued in 2014.
If you know of wrongdoing and are ready to blow the whistle, please contact the AntiFraud Law Group online or by calling (757) 223-4536 to schedule a free case evaluation. Located in Newport News, VA, our whistleblower lawyers handle cases throughout the country.